Our study demonstrated that delivery of granulysin by recombinant adenovirus to the infected lung via inhalation route could enhance the clearance of TB in vivo and immunotherapy with both rAdhGLs and rAdhGLi is a very promising adjunct for chemotherapy against TB, especially for MDR-TB and XDR-TB. The gene discussed is GNLY; the disease is tuberculosis.